SCHEMBL23920054

SCHEMBL23920054

C[C@H]1COc2cc(Cl)ccc2N1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
CYP1A2 P05177 1/20 0.41
HPGD P15428 1/20 0.41
HSD17B10 Q99714 1/20 0.41
AR P10275 2/20 0.40
HTR2C P28335 1/20 0.36
MAP3K14 Q99558 1/20 0.36
HCRTR2 O43614 1/20 0.35
AHR P35869 1/20 0.35
PTPN1 P18031 1/20 0.35
DAO P14920 1/20 0.35
RIPK1 Q13546 1/20 0.34
CA2 P00918 2/20 0.34
CYP19A1 P11511 1/20 0.34
ALOX5 P09917 1/20 0.34
CA1 P00915 1/20 0.34
GRM1 Q13255 2/20 0.34
MAOB P27338 1/20 0.33
ALPL P05186 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23920052 1.00 KDM4E (0.41) KDM4EALDH1A1CYP1A2HPGDHSD17B10
SCHEMBL20798244 1.00 KDM4E (0.41) KDM4EALDH1A1CYP1A2HPGDHSD17B10
SCHEMBL11850014 0.86 AR (0.40) KDM4EALDH1A1CYP1A2HPGDHSD17B10
SCHEMBL9845271 0.81 AR (0.41) KDM4EALDH1A1HPGDHSD17B10AR
SCHEMBL8641161 0.79 BRD4 (0.44) ARMAOB
SCHEMBL10494909 0.79 AR (0.40) KDM4EALDH1A1CYP1A2HSD17B10AR
SCHEMBL9035075 0.79 AR (0.43) ARHTR2CHCRTR2DAOCA2
SCHEMBL23920195 0.79 MAP3K14 (0.36) KDM4EALDH1A1CYP1A2HPGDHSD17B10
SCHEMBL10197527 0.79 AR (0.40) ARHTR2CHCRTR2AHRCA2
SCHEMBL9035064 0.79 AR (0.43) ARHTR2CHCRTR2DAOCA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210317102-A1 INHIBITORS OF INTEGRATED STRESS RESPONSE PATHWAY ALTOS LABS, INC. 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210317102-A1 INHIBITORS OF INTEGRATED STRESS RESPONSE PATHWAY ATF4, DDIT3, ATF1 KDM4E 4626/4885ALDH1A1 4073/4885CYP1A2 4440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.